Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CICA-RT
2019-001711-23Phase 3Completed
- Sponsor
- Centre Léon Bérard
- Start
- Nov 2019
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Cicaderma in breast cancer and radiodermatitis (2 arms), sponsored by Centre Léon Bérard. Started Nov 2019; status: completed.
02
Drugs
Cicaderma
03
Conditions
breast cancerradiodermatitis
Beyond the preview
Go deeper on 2019-001711-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001711-23.